- Cuba Salud 2018 - 16 a 20 abr. 2018 - XII Curso de Revisão em Hematologia e Hematerapia - 26 a 29 jun. 2018 - 12º Congresso Brasileiro de Saúde Coletiva – ABRASCÃO 2018 – 26 a 29 jul. 2018 - X Congresso Regional de Informação em Ciências da Saúde – CRICS10 – 4 a 6 dez. 2018
TUBERCULOSE (1)
ANDRADE, K. F. et al. Effects of social protection on tuberculosis treatment outcomes in low or middle-income and in high-burden countries: systematic review and meta-analysis. Cadernos de Saúde Pública, Rio de Janeiro, v.34, n.1. e00153116, Jan. 2018.
(2) (3) (4) (5) (6) (7) (8) (9) (10)
LOPEZ-LOPEZ, N. et al. Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v.113, n.4, e170326, 2018.
ABBASI, J. Urine test for tuberculosis in development. JAMA, Chicago, v.319, n . 6, p. 539, Feb. 2018.
PRADO, T. N. et al. Prevalence and risk factors for latent tuberculosis infection among primary health care workers in Brazil. Cadernos de Saúde Pública, Rio de Janeiro, v.33, n.12. 2017.
PINTO, M. F. T. et al. Impacto orçamentário da incorporação do GeneXpert MTB/RIF para o diagnóstico da tuberculose pulmonar na perspectiva do Sistema Único de Saúde, Brasil, 2013-2017. Cadernos de Saúde Pública, Rio de Janeiro, v.33, n.9. 2017.
FONSECA, B. P. F. et al. Network analysis for science and technology management: Evidence from tuberculosis research in Fiocruz, Brazil. PLoS One, San Francisco, v. 12, n. 8, e0181870, 2017.
AHMED, B. H. H. et al. Glutaraldehyde test for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an area with high tuberculosis incidence. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v.112, n.11, p. 779-784, nov. 2017.
La MANNA, M. P. et al. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease. PLoS ONE, San Francisco, v. 13, n. 3, e0192664, Mar. 2018.
MOLINA-MOYA, B. et al. Mycobacterium tuberculosis complex genotypes circulating in Nigeria based on spoligotyping obtained from Ziehl-Neelsen stained slides extracted DNA. PloS neglected tropical diseases, San Francisco, v.12, n.2, e0006242, Feb. 2018.
ABBASI, J. Urine test for tuberculosis in development. JAMA, Chicago, v.319, n . 6, p. 539, Feb. 2018.
ÚLCERA DE BURULI (1) (2) (3) (4) (5)
ABOAGYE, S. Y. et al. Environmental and behavioral drivers of buruli ulcer disease in selected communities along the Densu River Basin of Ghana: a case-control study The American Journal of Tropical Medicine and Hygiene, v . 96, n. 5, p. 1076 – 1083, May 2017.
MAMAN I. et al. Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region. BMC Infectious Diseases, London, v.18, n. 1, p. 48-59, Jan. 2018.
AMOUSSOUHOUI, A.S. et al. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa. PloS neglected tropical diseases, San Francisco, v.12, n.3, e0006291, Mar. 2018.
ANOKYE, R.; ACHEAMPONG, E.; MPRAH, W. K. ; SARPONG, E. Perceived causes and risk factors of Buruli ulcer among patients at Agogo Presbyterian hospital in Ashanti Region of Ghana. BMC Research Notes, London, v.11, n. 1, p. 64-68, Jan. 2018.
ZINGUE, D.; BOUAM, A. ; MILITELLO, M. ; DRANCOURT, M. High-Throughput Carbon Substrate Profiling of Mycobacterium ulcerans Suggests Potential Environmental Reservoirs. PloS neglected tropical diseases, San Francisco, v.11, n.1, e0005303, Jan. 2017.
(1) (2) (3) (4) (5)
GHAFELE, R.; BOGETOFT, R. K. Using patent valuation methods to assess damages in patent infringement cases under the Unified Patent Court. World patent information, Munchen, v. 52, p. 1-8, Mar. 2018.
'T HOEN, E. F. ; VERALDI, J.; TOEBES, B.; HOGERZEIL, H. V. Medicine procurement and the use of flexibilities in the agreement on trade-related aspects of intellectual property rights, 2001-2016. Bulletin of the World Health Organization Geneve, v. 96, n. 3, p. 185-193, Mar. 2018.
ADRIANO, E.; ANTUNES, M. T. P. Proposta para mensuração de patentes. Revista de administração contemporânea, Curitiba, v. 21, n. 1, p.125-141, Fev. 2017.
PIMENTA, F. P. A patente como fonte de informação (des)necessária para a Biotecnologia em Saúde. Transinformação, Campinas, v.29, n.3, p.323-332. set./dez 2017.
AKINSOLU, F. T. ; DE PAIVA, V. N. ; SOUZA, S. S. ; VARGA, O. Patent landscape of neglected tropical diseases: an analysis of worldwide patent families. Globalization and Health, London, v. 13, n. 1, p. 82, Nov. 2017.
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br